AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 26152495 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed post-test (DPT)
Number of subjects: 115
Study 26152495 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-assessed certainty (Definitely) during IPT
Number of subjects: 115
Study 26152495 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-assessed certainty (Definitely) during DPT
Number of subjects: 115
Study 26152495 — intervention group
Group type: EXPERIMENTAL
Intervention: Choosing Definitely over Probably
Number of subjects: 115
Study 26152495 — intervention group
Group type: EXPERIMENTAL
Intervention: Interaction between test timing and certainty
Number of subjects: 115
Study 23558770 — intervention group
Group type: EXPERIMENTAL
Intervention: ICM group (AH at the site near the inner cell mass)
Number of subjects: 160
Study 23558770 — intervention group
Group type: COMPARATOR
Intervention: TE group (AH at the site opposite to the ICM)
Number of subjects: 160
Study 23558770 — intervention group
Group type: EXPERIMENTAL
Intervention: ICM group
Number of subjects: 160
Study 23558770 — intervention group
Group type: COMPARATOR
Intervention: TE group
Number of subjects: 160
Study 22013155 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic casting method for foot orthoses
Number of subjects: 12
Study 22013155 — intervention group
Group type: COMPARATOR
Intervention: Static casting method for foot orthoses
Number of subjects: 12
Study 19255890 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil capsules (1,260 mg eicosapentaenoic acid and 540 mg docosahexaenoic acid/day)
Number of subjects: 0
Study 19255890 — intervention group
Group type: COMPARATOR
Intervention: Olive oil (placebo) capsules
Number of subjects: 0
Study 16499636 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy (SLIT)
Number of subjects: 25
Study 16499636 — intervention group
Group type: COMPARATOR
Intervention: Untreated (UT)
Number of subjects: 25
Study 12921816 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiotensin‐receptor blockade (ARB) with valsartan
Number of subjects: 14703
Study 12921816 — intervention group
Group type: COMPARATOR
Intervention: Angiotensin‐converting enzyme inhibition (ACEI) with captopril
Number of subjects: 14703
Study 12921816 — intervention group
Group type: EXPERIMENTAL
Intervention: Both ARB and ACEI
Number of subjects: 14703
Study 10534827 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemedical prenatal monitoring
Number of subjects: 263
Study 10534827 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard prenatal care)
Number of subjects: 263
Study 8546481 — intervention group
Group type: EXPERIMENTAL
Intervention: Three-pulse treatment group (200 mg itraconazole twice daily for 1 week each month)
Number of subjects: 50
Study 8546481 — intervention group
Group type: EXPERIMENTAL
Intervention: Four-pulse treatment group (200 mg itraconazole twice daily for 1 week each month)
Number of subjects: 50
Study 2063675 — intervention group
Group type: EXPERIMENTAL
Intervention: Phototherapy (PT)
Number of subjects: 29
Study 2063675 — intervention group
Group type: COMPARATOR
Intervention: Non-phototherapy (non-PT)
Number of subjects: 29
Study 2063675 — intervention group
Group type: COMPARATOR
Intervention: Control group (serum bilirubin < 12 mg/dl)
Number of subjects: 29
Study 6356865 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxprenolol
Number of subjects: 0
Study 6356865 — intervention group
Group type: COMPARATOR
Intervention: Propranolol
Number of subjects: 0
Study 3914859 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftazidime (500 mg intravenously every 12 h)
Number of subjects: 67
Study 3914859 — intervention group
Group type: COMPARATOR
Intervention: Moxalactam (500 mg intravenously every 12 h; 2 g for Pseudomonas aeruginosa)
Number of subjects: 67
Study 29024341 — intervention group
Group type: EXPERIMENTAL
Intervention: Low glycemic index diet (LGI)
Number of subjects: 48
Study 29024341 — intervention group
Group type: EXPERIMENTAL
Intervention: High glycemic index diet (HGI)
Number of subjects: 48
Study 29024341 — intervention group
Group type: COMPARATOR
Intervention: Low-fat diet (LF)
Number of subjects: 48
Study 29024341 — intervention group
Group type: EXPERIMENTAL
Intervention: Tertile 1 (BW change)
Number of subjects: 48
Study 29024341 — intervention group
Group type: EXPERIMENTAL
Intervention: Tertile 2 (waist circumference)
Number of subjects: 48
Study 29024341 — intervention group
Group type: EXPERIMENTAL
Intervention: Tertile 1 (fat mass)
Number of subjects: 48
Study 26394246 — intervention group
Group type: EXPERIMENTAL
Intervention: HOOP (uncommon exercise stimulus)
Number of subjects: 120
Study 26394246 — intervention group
Group type: COMPARATOR
Intervention: WALK (common exercise stimulus)
Number of subjects: 120
Study 24944129 — intervention group
Group type: EXPERIMENTAL
Intervention: Football group (FG)
Number of subjects: 20
Study 24944129 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 20
Study 22636824 — intervention group
Group type: EXPERIMENTAL
Intervention: Increase fruit/vegetable intake and decrease sedentary leisure
Number of subjects: 204
Study 22636824 — intervention group
Group type: EXPERIMENTAL
Intervention: Decrease fat and increase physical activity
Number of subjects: 204
Study 22636824 — intervention group
Group type: EXPERIMENTAL
Intervention: Decrease fat and decrease sedentary leisure
Number of subjects: 204
Study 22636824 — intervention group
Group type: EXPERIMENTAL
Intervention: Increase fruit/vegetable intake and increase physical activity
Number of subjects: 204
Study 20423561 — intervention group
Group type: EXPERIMENTAL
Intervention: Anserine (specific doses, intraperitoneal administration)
Number of subjects: 0
Study 20423561 — intervention group
Group type: EXPERIMENTAL
Intervention: Anserine (0.1 mg, intraduodenal injection)
Number of subjects: 0
Study 20423561 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral administration of anserine
Number of subjects: 0
Study 20423561 — intervention group
Group type: COMPARATOR
Intervention: Thioperamide (control)
Number of subjects: 0
Study 18286418 — intervention group
Group type: EXPERIMENTAL
Intervention: Lenient recall instructions (recall everything, not worry about mistakes)
Number of subjects: 0
Study 18286418 — intervention group
Group type: EXPERIMENTAL
Intervention: Strict recall instructions (recall only if sure of accuracy)
Number of subjects: 0
Study 18286418 — intervention group
Group type: EXPERIMENTAL
Intervention: Criterion manipulation in memory recognition with a confederate
Number of subjects: 0
Study 18286418 — intervention group
Group type: EXPERIMENTAL
Intervention: Varied level of secrecy in responses
Number of subjects: 0
Study 16412924 — intervention group
Group type: EXPERIMENTAL
Intervention: Nuclear cataract patients
Number of subjects: 100
Study 16412924 — intervention group
Group type: EXPERIMENTAL
Intervention: Posterior subcapsular cataract patients
Number of subjects: 100
Study 16412924 — intervention group
Group type: EXPERIMENTAL
Intervention: ARMD patients
Number of subjects: 100
Study 16412924 — intervention group
Group type: COMPARATOR
Intervention: Controls
Number of subjects: 100
Study 16412924 — intervention group
Group type: EXPERIMENTAL
Intervention: Nuclear cataract and ARMD patients
Number of subjects: 100
Study 16412924 — intervention group
Group type: EXPERIMENTAL
Intervention: Posterior subcapsular cataract and ARMD patients
Number of subjects: 100
Study 12846845 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoridated milk (200 ml per day, concentration 2.5 mg F- per litre) consumed from Monday to Friday in kindergarten and two packs of fluoridated milk (250 ml) for home consumption on weekends.
Number of subjects: 534
Study 12846845 — intervention group
Group type: COMPARATOR
Intervention: Control group (children without access to fluoridated milk).
Number of subjects: 534
Study 10512601 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine 20 mg daily for up to 8 weeks with ERT
Number of subjects: 172
Study 10512601 — intervention group
Group type: COMPARATOR
Intervention: Fluoxetine 20 mg daily for up to 8 weeks without ERT
Number of subjects: 172
Study 10512601 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine responders treated up to 26 weeks
Number of subjects: 172
Study 8744879 — intervention group
Group type: EXPERIMENTAL
Intervention: Physicians provided with Hamilton Depression rating scale (HAM-D) scores and patient-specific treatment recommendations
Number of subjects: 222
Study 8744879 — intervention group
Group type: COMPARATOR
Intervention: Physicians not provided HAM-D scores
Number of subjects: 222
Study 8744879 — intervention group
Group type: EXPERIMENTAL
Intervention: Provision of treatment algorithms
Number of subjects: 222
Study 1755876 — intervention group
Group type: COMPARATOR
Intervention: Regular smokers
Number of subjects: 491
Study 1755876 — intervention group
Group type: EXPERIMENTAL
Intervention: Smokers given counselling
Number of subjects: 491
Study 6314097 — intervention group
Group type: COMPARATOR
Intervention: Conjugated equine oestrogens
Number of subjects: 2
Study 6314097 — intervention group
Group type: EXPERIMENTAL
Intervention: Piperazine oestrone sulphate
Number of subjects: 2
Study 30465175 — intervention group
Group type: EXPERIMENTAL
Intervention: Acotiamide 300 mg/day for 2 weeks
Number of subjects: 71
Study 30465175 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 2 weeks
Number of subjects: 71
Study 30015604 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual food choices identified using the Apriori algorithm
Number of subjects: 433
Study 30015604 — intervention group
Group type: EXPERIMENTAL
Intervention: Breakfast food choices
Number of subjects: 433
Study 30015604 — intervention group
Group type: EXPERIMENTAL
Intervention: Lunch food choices
Number of subjects: 433
Study 30015604 — intervention group
Group type: EXPERIMENTAL
Intervention: Dinner food choices
Number of subjects: 433
Study 30015604 — intervention group
Group type: EXPERIMENTAL
Intervention: Other meal choices
Number of subjects: 433
Study 26853954 — intervention group
Group type: EXPERIMENTAL
Intervention: Active group (≥1 min/week exercise)
Number of subjects: 902
Study 26853954 — intervention group
Group type: COMPARATOR
Intervention: Inactive group (0 min/week exercise)
Number of subjects: 902
Study 26853954 — intervention group
Group type: EXPERIMENTAL
Intervention: Modest exercise (1 to 89 min/week)
Number of subjects: 902
Study 26853954 — intervention group
Group type: EXPERIMENTAL
Intervention: Television screen time (>4 vs <2 h/day)
Number of subjects: 902
Study 25150954 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral letrozole (2.5mg/day) and norethindrone acetate (2.5mg/day) for three months prior to surgery (group A)
Number of subjects: 80
Study 25150954 — intervention group
Group type: COMPARATOR
Intervention: No treatment before surgery (group B)
Number of subjects: 80
Study 21947680 — intervention group
Group type: EXPERIMENTAL
Intervention: Arm A (21-day cycles: capecitabine 1,000 mg/m2 twice daily, days 1-14; paclitaxel 60 mg/m2, days 1, 8, and 15)
Number of subjects: 130
Study 21947680 — intervention group
Group type: COMPARATOR
Intervention: Arm B (28-day cycles: capecitabine 1,000 mg/m2 twice daily, days 1-5, 8-12, and 15-19; paclitaxel 80 mg/m2, days 1, 8, and 15)
Number of subjects: 130
Study 19153970 — intervention group
Group type: EXPERIMENTAL
Intervention: Doubly robust generalized estimating equations (DR GEE)
Number of subjects: 0
Study 19153970 — intervention group
Group type: EXPERIMENTAL
Intervention: Weighted generalized estimating equations (WGEE)
Number of subjects: 0
Study 19153970 — intervention group
Group type: EXPERIMENTAL
Intervention: Imputation methods
Number of subjects: 0
Study 19153970 — intervention group
Group type: EXPERIMENTAL
Intervention: INITIO randomized clinical trial of HIV therapy
Number of subjects: 0
Study 17555692 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium hydroxide (CH)
Number of subjects: 34
Study 17555692 — intervention group
Group type: COMPARATOR
Intervention: Mineral trioxide aggregates (MTA)
Number of subjects: 34
Study 15789590 — intervention group
Group type: EXPERIMENTAL
Intervention: Dose-Volume Histogram (DVH)
Number of subjects: 60
Study 15789590 — intervention group
Group type: EXPERIMENTAL
Intervention: Dose-Surface Histogram (DSH)
Number of subjects: 60
Study 15789590 — intervention group
Group type: EXPERIMENTAL
Intervention: Digitized computation
Number of subjects: 60
Study 12218390 — intervention group
Group type: EXPERIMENTAL
Intervention: Niacin, 3000 mg/day for > or = 6 months
Number of subjects: 70
Study 12218390 — intervention group
Group type: COMPARATOR
Intervention: Not applicable (control group)
Number of subjects: 70
Study 12218390 — intervention group
Group type: COMPARATOR
Intervention: Not applicable (self-perceived IAF expansion group)
Number of subjects: 70
Study 12218390 — intervention group
Group type: COMPARATOR
Intervention: Not applicable (IAF area comparison)
Number of subjects: 70
Study 10485774 — intervention group
Group type: EXPERIMENTAL
Intervention: IVRA with clonidine (1 microg/kg)
Number of subjects: 45
Study 10485774 — intervention group
Group type: COMPARATOR
Intervention: Control (intravenous saline)
Number of subjects: 45
Study 10485774 — intervention group
Group type: COMPARATOR
Intervention: Intravenous clonidine (1 microg/kg)
Number of subjects: 45
Study 8930781 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (FP) 500 micrograms
Number of subjects: 12
Study 8930781 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (FP) 1000 micrograms
Number of subjects: 12
Study 8930781 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (FP) 2000 micrograms
Number of subjects: 12
Study 1992574 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment (total androgen blockade with nilutamide)
Number of subjects: 208
Study 1992574 — intervention group
Group type: COMPARATOR
Intervention: Simple castration
Number of subjects: 208
Study 6606393 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxalactam, 250 mg every 12 h
Number of subjects: 49
Study 6606393 — intervention group
Group type: COMPARATOR
Intervention: Gentamicin, 1 mg/kg every 8 h
Number of subjects: 49
Study 6606393 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxalactam
Number of subjects: 49
Study 31842773 — intervention group
Group type: EXPERIMENTAL
Intervention: Xpert arm
Number of subjects: 6041
Study 31842773 — intervention group
Group type: COMPARATOR
Intervention: Smear arm
Number of subjects: 6041
Study 30204821 — intervention group
Group type: COMPARATOR
Intervention: Kinesio tape (KT)
Number of subjects: 33
Study 30204821 — intervention group
Group type: EXPERIMENTAL
Intervention: Proprioceptive-neuromuscular (PN) training
Number of subjects: 33
Study 30204821 — intervention group
Group type: COMPARATOR
Intervention: Control (modern dance technique classes)
Number of subjects: 33
Study 26860641 — intervention group
Group type: EXPERIMENTAL
Intervention: Patent lower extremity bypass (LEB) grafts
Number of subjects: 1404
Study 26860641 — intervention group
Group type: EXPERIMENTAL
Intervention: Critical stenosis
Number of subjects: 1404
Study 26860641 — intervention group
Group type: EXPERIMENTAL
Intervention: Revision of critical stenosis
Number of subjects: 1404
Study 26860641 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative gangrene
Number of subjects: 1404
Study 26860641 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes
Number of subjects: 1404
Study 26860641 — intervention group
Group type: EXPERIMENTAL
Intervention: Black race vs white race
Number of subjects: 1404
Study 26860641 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline creatinine clearance <25 mL/min vs >65 mL/min
Number of subjects: 1404
Study 26860641 — intervention group
Group type: EXPERIMENTAL
Intervention: Prior history of coronary artery bypass grafting
Number of subjects: 1404
Study 26860641 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower baseline activity quality of life score
Number of subjects: 1404
Study 26860641 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative gangrenous changes
Number of subjects: 1404
Study 26860641 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical wound necrosis
Number of subjects: 1404
Study 26860641 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep wound infection vs superficial wound infection
Number of subjects: 1404
Study 26860641 — intervention group
Group type: EXPERIMENTAL
Intervention: Wound healing abnormally
Number of subjects: 1404
Study 26860641 — intervention group
Group type: EXPERIMENTAL
Intervention: Recurrent CLI symptoms
Number of subjects: 1404
Study 26860641 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe adverse event vs mild adverse event
Number of subjects: 1404
Study 26860641 — intervention group
Group type: EXPERIMENTAL
Intervention: Fewer percutaneous revisions
Number of subjects: 1404
Study 26860641 — intervention group
Group type: EXPERIMENTAL
Intervention: Discharge on low-molecular-weight heparin
Number of subjects: 1404
Study 26860641 — intervention group
Group type: EXPERIMENTAL
Intervention: Decreasing days to critical stenosis/occlusion/revision/amputation
Number of subjects: 1404
Study 24916552 — intervention group
Group type: EXPERIMENTAL
Intervention: Ice cream
Number of subjects: 11
Study 24916552 — intervention group
Group type: EXPERIMENTAL
Intervention: Fat/protein component in ice cream
Number of subjects: 11
Study 24916552 — intervention group
Group type: EXPERIMENTAL
Intervention: Sugar equivalent component in ice cream
Number of subjects: 11
Study 24916552 — intervention group
Group type: COMPARATOR
Intervention: Avocado (kilojoule-equivalent meal)
Number of subjects: 11
Study 22684984 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin (250 mg M-W-F for 18-35.9 kg; 500 mg M-W-F for ≥36 kg)
Number of subjects: 146
Study 22684984 — intervention group
Group type: COMPARATOR
Intervention: Placebo (initially) then Azithromycin
Number of subjects: 146
Study 20433751 — intervention group
Group type: EXPERIMENTAL
Intervention: Phytotherapic compound containing Pimpinella anisum, Foeniculum vulgare, Sambucus nigra, and Cassia augustifolia for 5 days
Number of subjects: 20
Study 20433751 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 5 days
Number of subjects: 20
Study 18608063 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-intensity exercise training (30 minutes of aerobic training followed by resistance training, twice weekly for six weeks)
Number of subjects: 40
Study 18608063 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercise intervention)
Number of subjects: 40
Study 15947903 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 628
Study 15947903 — intervention group
Group type: COMPARATOR
Intervention: PDE5 inhibitors
Number of subjects: 628
Study 11961396 — intervention group
Group type: EXPERIMENTAL
Intervention: L-threo-3,4-dihydroxyphenylserine (L-DOPS) 400 mg
Number of subjects: 149
Study 11961396 — intervention group
Group type: EXPERIMENTAL
Intervention: L-threo-3,4-dihydroxyphenylserine (L-DOPS) 200 mg
Number of subjects: 149
Study 11961396 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 149
Study 10205197 — intervention group
Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (MMF) plus corticosteroids
Number of subjects: 70
Study 10205197 — intervention group
Group type: COMPARATOR
Intervention: Azathioprine plus corticosteroids
Number of subjects: 70
Study 7629406 — intervention group
Group type: EXPERIMENTAL
Intervention: naloxone (0.4 mg/kg)
Number of subjects: 28
Study 7629406 — intervention group
Group type: COMPARATOR
Intervention: vehicle
Number of subjects: 28
Study 7629406 — intervention group
Group type: EXPERIMENTAL
Intervention: ambulatory blood pressure and heart rates
Number of subjects: 28
Study 2393295 — intervention group
Group type: EXPERIMENTAL
Intervention: Amifloxacin 200 mg q12h
Number of subjects: 6
Study 2393295 — intervention group
Group type: EXPERIMENTAL
Intervention: Amifloxacin 400 mg q12h
Number of subjects: 6
Study 2393295 — intervention group
Group type: EXPERIMENTAL
Intervention: Amifloxacin 600 mg q12h
Number of subjects: 6
Study 2393295 — intervention group
Group type: EXPERIMENTAL
Intervention: Amifloxacin 400 mg q8h
Number of subjects: 6
Study 2393295 — intervention group
Group type: EXPERIMENTAL
Intervention: Amifloxacin 600 mg q8h
Number of subjects: 6
Study 2393295 — intervention group
Group type: EXPERIMENTAL
Intervention: Amifloxacin 800 mg q8h
Number of subjects: 6
Study 2393295 — intervention group
Group type: EXPERIMENTAL
Intervention: Amifloxacin (all doses)
Number of subjects: 6
Study 2393295 — intervention group
Group type: EXPERIMENTAL
Intervention: Amifloxacin (doses above 1200 mg/day)
Number of subjects: 6
Study 871444 — intervention group
Group type: EXPERIMENTAL
Intervention: Freon 11, Freon 12, Freon 114, and mixtures of these propellants
Number of subjects: 10
Study 30551146 — intervention group
Group type: EXPERIMENTAL
Intervention: Hatha yoga (n = 25)
Number of subjects: 55
Study 30551146 — intervention group
Group type: COMPARATOR
Intervention: Wellness control (reading educational materials about healthy lifestyle; n = 30)
Number of subjects: 55
Study 31038996 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive pressure ventilation
Number of subjects: 360
Study 31038996 — intervention group
Group type: COMPARATOR
Intervention: No positive pressure ventilation
Number of subjects: 360
Study 28472015 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic-assisted TAP block
Number of subjects: 60
Study 28472015 — intervention group
Group type: COMPARATOR
Intervention: Ultrasound-guided TAP block
Number of subjects: 60
Study 25231116 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerometer-augmented PLGS algorithm
Number of subjects: 18
Study 25231116 — intervention group
Group type: COMPARATOR
Intervention: Regular basal insulin rate (Control)
Number of subjects: 18
Study 23731705 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcatheter Aortic Valve Implantation (TAVI)
Number of subjects: 78
Study 23731705 — intervention group
Group type: COMPARATOR
Intervention: Aortic Valve Replacement (AVR)
Number of subjects: 78
Study 20850953 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelargonium sidoides extract
Number of subjects: 0
Study 20850953 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 19496957 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous magnesium (70 mg/kg magnesium sulphate infusions in 4 hours for 5 days)
Number of subjects: 10
Study 19496957 — intervention group
Group type: COMPARATOR
Intervention: NaCl 0.9% solutions (control for blinding purposes)
Number of subjects: 10
Study 16957566 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosiglitazone plus metformin
Number of subjects: 389
Study 16957566 — intervention group
Group type: COMPARATOR
Intervention: Glyburide plus metformin
Number of subjects: 389
Study 15352664 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative EMG monitoring (n = 67)
Number of subjects: 112
Study 15352664 — intervention group
Group type: COMPARATOR
Intervention: Control group without EMG monitoring (n = 45)
Number of subjects: 112